Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/4236
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJone Kirubavathy, S-
dc.contributor.authorVelmurugan, R-
dc.contributor.authorKarvembu, R-
dc.contributor.authorBhuvanesh, N S P-
dc.contributor.authorParameswari, K-
dc.contributor.authorChitra, S-
dc.date.accessioned2023-11-15T06:00:40Z-
dc.date.available2023-11-15T06:00:40Z-
dc.date.issued2015-04-07-
dc.identifier.urihttps://link.springer.com/article/10.1134/S1070328415050048-
dc.description.abstractA Co(III) Schiff base complex with the formula [Co(L)2]Cl · H2O (I) (L = monoanionic tridentate Schiff base ligand derived from salicylaldehyde and ethylene diamine) has been synthesized and characterized by elemental analysis and spectroscopic techniques. The structure of I was confirmed by single crystal X-ray diffraction studies (CIF file CCDC no. 1009967), which showed the presence of two Schiff base molecules in an octahedral fashion. The complex has been screened for its in vitro antibacterial and anticancer activities. Complex I was found to be more active in anti-microbial and anti-cancer activity than the ligand.en_US
dc.language.isoen_USen_US
dc.publisherSpringer Linken_US
dc.titleSYNTHESIS, STRUCTURE, AND PHARMACOLOGICAL EVALUATION OF CO(III) COMPLEX CONTAINING TRIDENTATE SCHIFF BASE LIGANDen_US
dc.typeArticleen_US
Appears in Collections:2.Article (30)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.